PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
A once-daily beverage containing T. fuciformis improved glycated hemoglobin A1c and waist circumference over 12 weeks [PMID:38439104]
In ApoE-/- mice, T. fuciformis decreased aortic root wall thickness and lipid droplet area while regulating lipid levels [PMID:39796594]
TFP inhibited high-fat diet-induced weight gain, fat accumulation, and blood glucose in mice via gut microbiota modulation [PMID:36545204]
Oral administration of TFPS showed significantly better efficacy than topical application in improving transdermal water loss and epidermal thickening in mice [PMID:36091780]
TFPs induced ferroptosis and decreased cell viability by inactivating NRF2/HO-1 signaling in vitro [PMID:38244583]
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 36757441 (2023) — The potential cutaneous benefits of Tremella fuciformis. · Archives of dermatological research
- 2.PMID: 38704064 (2024) — Cu-Tremella fuciformis polysaccharide-based tumor microenvironment-responsive injectable gels for cuproptosis-based synergistic osteosarcoma therapy. · International journal of biological macromolecules
- 3.PMID: 39796594 (2024) — Tremella fuciformis Berk Alleviated Atherosclerosis Symptoms via Nuclear Factor-Kappa B-Mediated Inflammatory Response in ApoE-/- Mice. · Nutrients
- 4.PMID: 37429350 (2023) — A chromosome-scale genome and proteome draft of Tremella fuciformis. · International journal of biological macromolecules
- 5.PMID: 30342120 (2019)